TuHURA Biosciences (HURA) Competitors $5.18 +0.20 (+4.02%) (As of 01:19 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsTrends HURA vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, AMPE, ARAV, ACABW, and ACABUShould you be buying TuHURA Biosciences stock or one of its competitors? The main competitors of TuHURA Biosciences include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Ampio Pharmaceuticals (AMPE), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Atlantic Coastal Acquisition Corp. II (ACABU). These companies are all part of the "pharmaceutical products" industry. TuHURA Biosciences vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Alvotech Ampio Pharmaceuticals Aravive Atlantic Coastal Acquisition Corp. II Atlantic Coastal Acquisition Corp. II TuHURA Biosciences (NASDAQ:HURA) and 180 Life Sciences (NASDAQ:ATNFW) are both manufacturing companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, community ranking, profitability, earnings and analyst recommendations. Does the media favor HURA or ATNFW? In the previous week, TuHURA Biosciences had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for TuHURA Biosciences and 0 mentions for 180 Life Sciences. TuHURA Biosciences' average media sentiment score of 1.00 beat 180 Life Sciences' score of 0.00 indicating that TuHURA Biosciences is being referred to more favorably in the media. Company Overall Sentiment TuHURA Biosciences Positive 180 Life Sciences Neutral Is HURA or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets TuHURA BiosciencesN/A N/A N/A 180 Life Sciences N/A N/A N/A Which has better earnings and valuation, HURA or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTuHURA BiosciencesN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Does the MarketBeat Community favor HURA or ATNFW? TuHURA Biosciences and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformTuHURA BiosciencesN/AN/A180 Life SciencesN/AN/A Do analysts prefer HURA or ATNFW? TuHURA Biosciences currently has a consensus target price of $15.00, suggesting a potential upside of 189.58%. Given TuHURA Biosciences' stronger consensus rating and higher probable upside, equities research analysts plainly believe TuHURA Biosciences is more favorable than 180 Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TuHURA Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00180 Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryTuHURA Biosciences beats 180 Life Sciences on 5 of the 5 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get TuHURA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HURA vs. The Competition Export to ExcelMetricTuHURA BiosciencesPharmaceutical Preparations IndustryManufacturing SectorNASDAQ ExchangeMarket CapN/A$6.85B$2.20B$8.79BDividend YieldN/A7.95%2.67%4.03%P/E RatioN/A8.6926.1316.06Price / SalesN/A411.21496.00103.52Price / CashN/A22.5640.2231.73Price / BookN/A5.512.254.69Net IncomeN/A$153.74M$165.18M$223.56M7 Day PerformanceN/A0.16%0.59%1.69%1 Month PerformanceN/A16.26%0.12%5.76%1 Year PerformanceN/A42.04%13.31%31.80% TuHURA Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HURATuHURA BiosciencesN/A$5.18+4.0%$15.00+189.6%N/A$0.00N/A0.00N/AUpcoming EarningsAnalyst ForecastPositive NewsATNFW180 Life SciencesN/A$0.01flatN/A-9.0%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AGap DownAEHAWAesther Healthcare AcquisitionN/A$0.05flatN/A-8.0%$0.00N/A0.002Gap UpAIMDWAinosN/A$0.03flatN/AN/A$0.00$65,122.000.0040Positive NewsALVOWAlvotechN/A$3.01-5.9%N/A+130.7%$0.00$306.77M0.004Positive NewsALVOAlvotech3.1896 of 5 stars$12.92-0.8%N/A+45.3%$0.00$93.38M-4.881,026Upcoming EarningsAMPEAmpio PharmaceuticalsN/A$0.00flatN/A-99.9%$0.00N/A0.0020ARAVAravive1.7906 of 5 stars$0.04flatN/AN/A$0.00$9.14M-0.0420News CoverageHigh Trading VolumeACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03flatN/A-45.5%$0.00N/A0.004Positive NewsACABUAtlantic Coastal Acquisition Corp. IIN/A$12.54flatN/A+19.1%$0.00N/A0.004Positive News Related Companies and Tools Related Companies ATNFW Competitors LBPSW Competitors AEHAW Competitors AIMDW Competitors ALVOW Competitors ALVO Competitors AMPE Competitors ARAV Competitors ACABW Competitors ACABU Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HURA) was last updated on 11/6/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredNASDAQ small cap that could be gearing up for a massive short squeeze.A Heavy Short Interest Could Lead to a Monstrous Short Squeeze for this Tiny NASDAQ Healthcare Firm!Huge Alerts | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElection Won – THESE Stocks Could BenefitThe election has been won – and select stocks are poised to benefit from President Trump's pro-business polici...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TuHURA Biosciences Please log in to your account or sign up in order to add this asset to your watchlist. Share TuHURA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.